Tocilizumab for the treatment of systemic juvenile idiopathic arthritis

  • Technology appraisal guidance
  • TA238
  • Published: 
Download guidance (PDF)

Update information

June 2024

The wording of the recommendation describing the commercial arrangement (see section 1.1), and in section 2.3, has been updated to include procurement information about tocilizumab biosimilars.

February 2014: minor maintenance

June 2012: minor maintenance

ISBN: 978-1-4731-6169-6